Lymphotoxins: New Targets for Hepatocellular Carcinoma

Augusto Villanueva; Radoslav Savic; Josep M. Llovet

doi:10.1016/j.ccr.2009.09.012

Lymphotoxins: New Targets for Hepatocellular Carcinoma

Augusto Villanueva
, Radoslav Savic
, Josep M. Llovet

Research output: Contribution to journal › Short survey › peer-review

16 Scopus citations

Abstract

In this issue of Cancer Cell, Haybaeck et al. unravel the role of lymphotoxin pathway in the development of hepatocellular carcinoma (HCC). Aberrant activation of this cascade in mice livers recapitulates the stages of fibrosis and inflammation that precedes human liver cancer, providing a novel family of potential therapeutic targets.

Original language	English
Pages (from-to)	272-273
Number of pages	2
Journal	Cancer Cell
Volume	16
Issue number	4
DOIs	https://doi.org/10.1016/j.ccr.2009.09.012
State	Published - 6 Oct 2009

Access to Document

10.1016/j.ccr.2009.09.012

Cite this

@article{c4dc1365e8684e40958d59785d8288cc,

title = "Lymphotoxins: New Targets for Hepatocellular Carcinoma",

abstract = "In this issue of Cancer Cell, Haybaeck et al. unravel the role of lymphotoxin pathway in the development of hepatocellular carcinoma (HCC). Aberrant activation of this cascade in mice livers recapitulates the stages of fibrosis and inflammation that precedes human liver cancer, providing a novel family of potential therapeutic targets.",

author = "Augusto Villanueva and Radoslav Savic and Llovet, \{Josep M.\}",

note = "Funding Information: A.V. is a recipient of a Sheila Sherlock (European Association for the Study of the Liver) fellowship. J.M.L. has grants from National Institute of Health -NIDDK 1R01DK076986-01, National Institute of Health (Spain) grant I+D Program (SAF-2007-61898), and Samuel Waxman Cancer Research Foundation.",

year = "2009",

month = oct,

day = "6",

doi = "10.1016/j.ccr.2009.09.012",

language = "English",

volume = "16",

pages = "272--273",

journal = "Cancer Cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "4",

}

TY - JOUR

T1 - Lymphotoxins

T2 - New Targets for Hepatocellular Carcinoma

AU - Villanueva, Augusto

AU - Savic, Radoslav

AU - Llovet, Josep M.

N1 - Funding Information: A.V. is a recipient of a Sheila Sherlock (European Association for the Study of the Liver) fellowship. J.M.L. has grants from National Institute of Health -NIDDK 1R01DK076986-01, National Institute of Health (Spain) grant I+D Program (SAF-2007-61898), and Samuel Waxman Cancer Research Foundation.

PY - 2009/10/6

Y1 - 2009/10/6

N2 - In this issue of Cancer Cell, Haybaeck et al. unravel the role of lymphotoxin pathway in the development of hepatocellular carcinoma (HCC). Aberrant activation of this cascade in mice livers recapitulates the stages of fibrosis and inflammation that precedes human liver cancer, providing a novel family of potential therapeutic targets.

AB - In this issue of Cancer Cell, Haybaeck et al. unravel the role of lymphotoxin pathway in the development of hepatocellular carcinoma (HCC). Aberrant activation of this cascade in mice livers recapitulates the stages of fibrosis and inflammation that precedes human liver cancer, providing a novel family of potential therapeutic targets.

UR - https://www.scopus.com/pages/publications/70349575079

U2 - 10.1016/j.ccr.2009.09.012

DO - 10.1016/j.ccr.2009.09.012

M3 - Short survey

C2 - 19800570

AN - SCOPUS:70349575079

SN - 1535-6108

VL - 16

SP - 272

EP - 273

JO - Cancer Cell

JF - Cancer Cell

IS - 4

ER -

Lymphotoxins: New Targets for Hepatocellular Carcinoma

Abstract

Access to Document

Fingerprint

Cite this